CRP and cancer: In line with our previous work (19), focusing on why cancer patients with elevated blood CRP levels have inferior outcomes, the hypothesis evolved that the potent monomeric/modified form of CRP may play a direct pro-inflammatory role within the TME of systemically inflamed cancer patients.